普雷加巴林是否有潜力作为一般性焦虑障碍的第一线治疗方法? 对疗效,安全性和成本效益的元分析
Narcis Cardoner1,2,3,4, Luis Gutiérrez-Rojas5,6, Pilar Saiz7,8,9,10,11
1Psychiatry Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Frontiers in pharmacology
|February 24, 2025
概括
普雷加巴林有效治疗泛性焦虑障碍 (GAD),与标准治疗相比,其疗效和安全性更高. 这一元分析证实了它对GAD患者的好处.
科学领域:
- 精神病学和临床心理学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 通用焦虑症 (GAD) 的患病率正在增加,导致个人和社会承担重大负担.
- GAD的低诊断导致负面的健康结果和增加的医疗保健成本.
- 对GAD有效的治疗选择至关重要,需要对像普雷加巴林这样的药物进行研究.
研究的目的:
- 评估普加巴林在治疗泛性焦虑症 (GAD) 的疗效和安全性.
- 为了确定普雷加巴林在GAD治疗中的最佳剂量.
- 为了比较pregabalin的有效性与已建立的治疗方法,如二胺类药物,SSRI和SNRIs.
主要方法:
- 根据PRISMA指南进行了一项元分析.
- 包括随机临床试验,比较普雷加巴林与二,SSRI,SNRIs或安慰剂.
- 使用HAM-A和CGI-I尺度测量有效性;通过不良事件和停药率评估安全性.
主要成果:
- 普雷加巴林在多个时间点显著降低了HAM-A得分,并与对照剂相比提高了响应率.
- 临床全球印象改善 (CGI-I) 评分偏好了普雷加巴林,表明患者报告的结果更好.
- 普雷加巴林的停药率较低,安全性较好,成本效益更高.
结论:
- 普雷加巴林是一种有效的,耐受性良好的治疗一般性焦虑障碍 (GAD).
- 与第一线治疗GAD的药物相比,它显示出更高的疗效和安全性.
- 这些发现支持pregabalin作为一种有价值的治疗选择,用于管理GAD症状.
关键词:
SNRIs是一般化焦虑障碍的SNRIs.这些SSRI是SSRI.这种类型的 benzodiazepines.有效性 有效性 有效性.普雷加巴林 (Pregabalin) 是一种药物.在安全方面,安全是安全的.更多相关视频
11:18Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
Published on: September 12, 2014
15.1K
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
30.9K
相关概念视频
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
454
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
454
01:30Generalized Anxiety Disorder
44
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
44
01:26Anxiolytic Drugs: Overview
212
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
212
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
309
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
309
01:20Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
01:18Anxiety: Overview
239
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
239